Who must Mike Stanton kill to make the bigs?

0 Comments

Stanton-mike.jpgThe Florida Marlins sent Mike Stanton down to Double-A Jacksonville on Wednesday. (No not this Mike Stanton, this Mike Stanton. You know, the guy who hit 28 home runs in 129 minor league games last season.)

Anyway, the strong, young, Marlins’ version of Mike Stanton might not be down on the farm too long, as Marlins manager Fredi Gonzalez sounds eager for his star prospect to bash his way to the bigs, no matter who gets hurt along the way.

From the Miami Herald:

“We sent him down, but he’ll let us know when he’s ready,” Gonzalez said Wednesday before his team began warming up to take on the Minnesota Twins at Hammond Stadium. “It’s just a matter of him getting some at-bats and putting up some numbers or decapitating somebody down there. Maybe the league president will say get this guy out of here before he hurts somebody.”

The 6-foot-5, 230-pounder, who is ranked No. 3 on MLB.com’s Top 50 Prospects List, hit .333 with a .407 on base and .833 slugging in 24 spring at-bats. He also hit three home runs this spring, all off Major League Pitchers (although one was a Met, and none of the pitchers were decapitated or otherwise injured).

So consider this an official notice to pitchers of the Southern League: Don’t forget to duck.

Are you on Twitter? You can follow Bob here, and get all your HBT updates here.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.